Product Information
SUMATRIPTAN-NAPROXEN 85-500 MG is a generic product labeled by Aurobindo Pharma Limited, priced at $11.5865 per EA under NDC 65862092836. Its NADAC has been published 415 times since Jul 18, 2018.
Strength
500; 85 mg/1; mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862092836
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
NAPROXEN SODIUM; SUMATRIPTAN SUCCINATEApproval Type
Generic (ANDA)
FDA Application
ANDA207457On Market Since
2/15/2018
Pharmacological Classes
Price Statistics
The NADAC for SUMATRIPTAN-NAPROXEN 85-500 MG has been published 415 times since Jul 18, 2018, and over the history we have for it it has declined 76.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $11.5865 per EA |
|---|---|
| All-time high | $64.2190 (Nov 14, 2018) |
| All-time low | $11.5865 (Jun 17, 2026) |
| 52-week high | $19.8987 |
| 52-week low | $11.5865 |
| Median price | $22.0476 |
| Average price | $28.1325 |
| Largest weekly change | +47.6% (May 18, 2022) |
| Weeks tracked | 415 |
| Tracking since | Jul 18, 2018 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of SUMATRIPTAN-NAPROXEN 85-500 MG?
The current National Average Drug Acquisition Cost (NADAC) for SUMATRIPTAN-NAPROXEN 85-500 MG, manufactured by Aurobindo Pharma Limited, is $11.5865 per EA (NDC 65862092836), effective Jun 24, 2026.
How has the price of SUMATRIPTAN-NAPROXEN 85-500 MG changed over time?
Over the history we have for it, the NADAC for SUMATRIPTAN-NAPROXEN 85-500 MG has declined 76.1%. It has been tracked across 415 weekly CMS publications since Jul 18, 2018.
What are the highest and lowest recorded NADAC prices for SUMATRIPTAN-NAPROXEN 85-500 MG?
Since Jul 18, 2018, the NADAC for SUMATRIPTAN-NAPROXEN 85-500 MG has ranged from a low of $11.5865 (Jun 17, 2026) to a high of $64.2190 (Nov 14, 2018), with a median of $22.0476 per EA.
Are there cheaper alternatives to SUMATRIPTAN-NAPROXEN 85-500 MG?
2 NADAC-published products share the same active ingredient, strength, and dosage form as SUMATRIPTAN-NAPROXEN 85-500 MG, but none are currently priced below it.
Who manufactures SUMATRIPTAN-NAPROXEN 85-500 MG?
SUMATRIPTAN-NAPROXEN 85-500 MG (NDC 65862092836) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification